Long-range gene regulation network of the MGMT enhancer modulates glioma cell sensitivity to temozolomide

J Genet Genomics. 2021 Oct 20;48(10):946-949. doi: 10.1016/j.jgg.2021.06.015. Epub 2021 Jul 14.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antineoplastic Agents, Alkylating / pharmacology
  • Antineoplastic Agents, Alkylating / therapeutic use
  • Brain Neoplasms / drug therapy
  • Brain Neoplasms / genetics
  • Brain Neoplasms / pathology
  • Cell Line, Tumor
  • DNA Modification Methylases / genetics
  • DNA Modification Methylases / metabolism
  • DNA Repair Enzymes / genetics
  • DNA Repair Enzymes / metabolism
  • Dacarbazine / analogs & derivatives
  • Dacarbazine / pharmacology
  • Dacarbazine / therapeutic use
  • Enhancer Elements, Genetic* / genetics
  • Gene Expression Regulation, Neoplastic / drug effects
  • Gene Regulatory Networks* / drug effects
  • Glioma* / drug therapy
  • Glioma* / genetics
  • Glioma* / pathology
  • Humans
  • Temozolomide* / pharmacology
  • Temozolomide* / therapeutic use
  • Tumor Suppressor Proteins / genetics
  • Tumor Suppressor Proteins / metabolism

Substances

  • Temozolomide
  • MGMT protein, human
  • DNA Modification Methylases
  • Dacarbazine
  • DNA Repair Enzymes
  • Tumor Suppressor Proteins
  • Antineoplastic Agents, Alkylating